Swiss Intravenous and Intra-arterial Thrombolysis for Treatment of Acute Ischemic Stroke Registry

Summary

The clinical and radiological data of patients with an acute ischemic stroke treated with intravenous thrombolysis (IVT) or intraarterial thrombolysis (IAT) in a Swiss stroke unit are assessed in a Swiss Multicenter Thrombolysis Registry. Like in clinical routine, a clinical evaluation takes place in a 3-months follow-up. Furthermore quality of life is assessed with a standardized questionnaire. The aim of the registry is to compare the safety and efficacy of IVT and IAT in patients with acute ischemic stroke. The registry also helps to improve in-hospital-management of stroke patients.

Conditions

• Ischemic Stroke

Interventions

PROCEDURE

Intravenous Thrombolysis

i.V. thrombolysis with rtPa

PROCEDURE

Intraarterial Thrombolysis

Endovascular treatment with i.a. Urokinase or i.a. rtPA or mechanical recanalization techniques

Sponsors & Collaborators

• Swiss Heart Foundation

  collaborator OTHER

• University of Zurich

  collaborator OTHER

• University Hospital, Basel, Switzerland

  collaborator OTHER

• University Hospital, Geneva

  collaborator OTHER

• University of Lausanne Hospitals

  collaborator OTHER

• Kantonsspital Aarau

  collaborator OTHER

• Cantonal Hospital of St. Gallen

  collaborator OTHER

• Triemli Hospital

  collaborator OTHER

• Insel Gruppe AG, University Hospital Bern

  lead OTHER

Principal Investigators

• Marcel Arnold, MD Prof. · Dep. of Neurology, Bern University Hospital, Switzerland

• Krassen Nedeltechev, MD Prof. · Kantonsspital Aarau, Switzerland

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2007-12-31

Primary Completion

2015-03-31

Completion

2015-12-31

Countries

• Switzerland

Study Locations